Search results
Earnings call: Tandem Diabetes Care reports growth, new product success By Investing.com
Investing.com· 6 days agoTandem Diabetes Care (NASDAQ:TNDM) has announced a solid start to 2024, with worldwide sales...
Is the iPad Pro Ultra Retina XDR tandem OLED the world's best display indeed?
PhoneArena· 2 days agoThe two layers of organic diodes in tandem OLED displays means that each layer's separate virtues...
Buying Buzz: Tandem Diabetes Care Inc [TNDM] Director Allen Dick purchases 5,000 shares of the...
Knox Daily· 16 hours agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tandem Diabetes Care Inc shares valued at $94,778 ...
FDA issues recall for diabetes app after over 200 reported injuries
Popular Science via Yahoo News· 8 hours agoInitially approved by the FDA in February 2022, Tandem Medical Care’s t:connect iOS app was the...
Faulty insulin pump app led to hundreds of injuries, prompting recall
CBS News via Yahoo News· 2 hours agoThe software glitch has prompted the recall of more than 85,000 versions of a mobile app, called...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoTandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript May 2, 2024 Tandem...
Why you shouldn't expect Apple's new uber-bright 1000-nit 'Tandem' OLED screen tech to hit the PC...
PC Gamer via Yahoo News· 1 day agoApple has rolled out its latest iPad Pro and apart from the new M4 chip, which is pretty interesting...
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
Zacks· 7 days agoTandem Diabetes (TNDM) outperforms in the first quarter, backed by the demand for both t:slim X2 and...
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Flashes A Sell Signal
Investor's Business Daily· 6 days agoTandem Diabetes stock rocketed, surging well above a profit-taking zone after the insulin pump-maker...
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $36.00
ETF DAILY NEWS· 3 days agoTandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price increased by Robert W. Baird from $28.00 to $36.00 in a report issued on Friday morning, Benzinga reports ...